Scribd
Upload
351 views16 pages

Lead Modification in Drug Design

This document discusses principles of lead modification in drug design, including identifying the pharmacophore, functional group modification, structure-activity relationships, privileged structures, and structure modifications to increase potency and therapeutic index. It provides examples of each principle, such as modifying functional groups on a molecule to change its antibacterial or antidiabetic properties, using homologation and chain branching to alter a molecule's activities, and employing bioisosterism and combinatorial chemistry in drug development.

Uploaded by

vineet kureel
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
351 views16 pages

Lead Modification in Drug Design

This document discusses principles of lead modification in drug design, including identifying the pharmacophore, functional group modification, structure-activity relationships, privileged structures, and structure modifications to increase potency and therapeutic index. It provides examples of each principle, such as modifying functional groups on a molecule to change its antibacterial or antidiabetic properties, using homologation and chain branching to alter a molecule's activities, and employing bioisosterism and combinatorial chemistry in drug development.

Uploaded by

vineet kureel
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
  • Lead Modification Overview
  • Lead Modification: Drug Design and Development
  • Combinatorial Chemistry

Lead Modification

Principles of Drug design

Lead modification : Drug design and


development
1. Identification of the active part : the
pharmacophore
2. Functional group modification
3. SAR relationships
4. Privileged structures and drug-like molecules
5. Structure modifications to increase potency
and therapeutic index

1. Identification of the active part : the


pharmacophore

analgesic and
addictive

3-4 times
more potent
analgesic and
addictive

Less potent
analgesic and less
addictive

3200 times
more potent
analgesic and
less addictive

2. Functional group modification

R=NH2
carbutamide
Antibacterial
Antidiabetic

Antidiabetic

3. Structure Activity Relationship- SAR

4. Previleged structures and drug like


molecules

Benzodiazepines

5. Structure modifications to increase


potency and therapeutic index
a)
b)
c)
d)
e)

Homologation
Chain branching
Ring chain transformations
Bioisosterism
Combinatorial Chemistry

[Link]

[Link] Branching

Promethazine antispasmodic and antihistaminic activities predominate


Promazine reduced antispasmodic and anti-histaminic activities,
enhanced sedative and tranquilizer activities
Trimeprazine reduced tranquilizing activity with increased anti-pruritic activity

[Link] Chain Transformations


Reasons :
Increase lipophilicity
Decrease metabolism
Contraining the groups into a particular favorable
conformation

[Link]
Bioisosteres are substituents or groups that
have chemical or physical similarities, and
which produce broadly similar biological
properties.
Types
i. Classical
ii. Non-classical

i. Classical Bioisosteres
Classical bioisosteres are functional groups that possess similar valence
electron configurations.
For example,
oxygen and sulphur are both in column VI of the periodic table; thus, a
thioether (-C-S-C-) is a classical bioisosteric substitution for an ether (-CO-C-) functional group.

ii. Non-classical bioisosteres


Non-classical bioisosteres are functional groups with dissimilar
valence electron configurations;
for instance, a tetrazole moiety may be used to replace a
carboxylate since many biological systems are unable to
differentiate between these two very structurally distinctive
functional groups.

Ring replacement as bioisosteric


approach

Pharmacological Effects of
Bioisosterism
Structural holding other functionalities
where particular geometry, then size, shape
and hydrogen bonding is important
Pharmacokinetics for ADME of the drug,
where lipophilicity, pKa and hydrogen bonding
are important
Metabolism blocking or aiding metabolism

[Link] Chemistry
Chemical libraries comprising of building
blocks to give a diverse array of molecules
with a common scaffold
Advantages
Carried out on a solid (polymeric) support to aid
isolation and purification by simple flitration and
washing.
Example : peptide synthesis

Lead Modification Principles of Drug design
Lead modification : Drug design and development 1. Identification of the active part : the pharmacophore 2. Functional gr
1. Identification of the active part : the pharmacophore 3-4 times more potent analgesic and addictive analgesic and a
2. Functional group modification R=NH2 carbutamide Antibacterial Antidiabetic Antidiabetic
3. Structure Activity Relationship- SAR
4. Previleged structures and drug like molecules Benzodiazepines
5. Structure modifications to increase potency and therapeutic index a) Homologation b) Chain branching c) Ring chain tra
5.a.Homologation
5.b.Chain Branching Promethazine – antispasmodic and antihistaminic activities predominate Promazine – reduced antispasmodi
5.c.Ring Chain Transformations Reasons : •Increase lipophilicity •Decrease metabolism •Contraining the groups into a par

You might also like